BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nabi Biopharmaceuticals 

Corporate Headquarters-Research and Development Facility
12276 Wilkins Avenue
Rockville  Maryland  20852  U.S.A.
Phone: 301-770-3099 Fax: 301-770-3097


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Nabi Biopharmaceuticals (NABI) Announces Third Quarter 2012 Financial Results 11/9/2012 10:00:18 AM
Nabi Biopharmaceuticals (NABI) Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited (BTA.AX) 11/9/2012 9:51:12 AM
Nabi Biopharmaceuticals (NABI) Announces Special Cash Dividend 11/5/2012 9:27:04 AM
The Board of Nabi Biopharmaceuticals (NABI) Establishes Ratio for Reverse Stock Split 10/26/2012 6:36:19 AM
Nabi Biopharmaceuticals (NABI) Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Holdings Limited (BTA.AX) Stockholders 10/24/2012 8:45:26 AM
Biota Holdings Limited (BTA.AX) Announces Approval of Definitive Merger Agreement by Nabi Biopharmaceuticals (NABI) Shareholders 10/23/2012 8:46:40 AM
Nabi Biopharmaceuticals (NABI) Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited (BTA.AX) 10/19/2012 8:46:51 AM
Nabi Biopharmaceuticals (NABI) Announces Results of NicVAX® Phase II Study in Combination With Varenicline 10/17/2012 9:37:10 AM
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals (NABI) Stockholders Support Amended Transaction With Biota Holdings Limited (BTA.AX) at October 22nd Reconvened Special Meeting 10/16/2012 9:39:17 AM
Nabi Biopharmaceuticals (NABI) Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012 9/25/2012 9:36:19 AM
12345678910...